MARKET

IRMD

IRMD

IRadimed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.77
-0.60
-2.46%
After Hours: 23.77 0 0.00% 16:00 01/15 EST
OPEN
24.25
PREV CLOSE
24.37
HIGH
24.36
LOW
23.69
VOLUME
17.73K
TURNOVER
--
52 WEEK HIGH
28.43
52 WEEK LOW
14.42
MARKET CAP
291.65M
P/E (TTM)
75.13
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
IV Fluid Monitoring Devices Market Share 2021 by Key Findings, Emerging Growth Factors, Driving Factors by Manufacturers, Key Strategies of Business, Global Size Value Forecast to 2024 Report by Industry Research.co
Jan 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “IV Fluid Monitoring Devices...
The Express Wire · 5d ago
MRI Pulse Oximeters Market Size Rising at 5% CAGR During 2020-2025: Analysis of Key Players, Trends and Drivers
Market Insight Reports · 6d ago
MRI Compatible Patient Monitoring Systems Market Healthy Pace throughout the Forecast during 2017- 2027
Jan 11, 2021 (MARKITWIRED via COMTEX) -- MRI CompatiblePatient Monitoring Systems market players – iRadimed Corporation, FreseniusKabi AG, B. Braun Melsungen...
Markitwired · 6d ago
Is iRadimed Corporation (IRMD) A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third quarter. You can find articles about an individual hedge fund’s trades on numerous financial […]
Insider Monkey · 12/03/2020 03:12
Is iRadimed Corporation (IRMD) A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third qua...
Insider Monkey · 12/03/2020 03:12
Downgrade: Here's How This Analyst Sees IRadimed Corporation (NASDAQ:IRMD) Performing In The Near Term
Simply Wall St. · 11/02/2020 10:35
IRadimed (IRMD) Q3 Earnings and Revenues Top Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 120.00% and 3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 10/30/2020 13:35
IRadimed Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 30, 2020 / IRadimed Corp. (NASDAQ:IRMD) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 30, 2020 at 11:00 AM Eastern Time.
ACCESSWIRE · 10/30/2020 13:32
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IRMD. Analyze the recent business situations of IRadimed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IRMD stock price target is 28.00 with a high estimate of 30.00 and a low estimate of 26.00.
EPS
Institutional Holdings
Institutions: 99
Institutional Holdings: 5.54M
% Owned: 45.14%
Shares Outstanding: 12.27M
TypeInstitutionsShares
Increased
18
380.19K
New
12
-123.08K
Decreased
29
245.84K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.03%
Healthcare Equipment & Supplies
+0.13%
Key Executives
Chairman/President/Chief Executive Officer/Founder/Chief Technology Officer/Director
Roger Susi
Chief Financial Officer/Secretary
Chris Scott
Vice President/Director of Sales
MaryBeth Smith
Vice President
Steven Kachelmeyer
Vice President
Steve Nardi
Vice President
Fran Casey
Vice President - Research & Development
Lynn Neuhardt
Independent Director
Monty Allen
Independent Director
James Hawkins
Independent Director
Anthony Vuoto
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About IRMD
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Iradimed Corp stock information, including NASDAQ:IRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRMD stock methods without spending real money on the virtual paper trading platform.